Introduction
The carcinogenic and mutagenic characteristics of benzene have been the subject of extensive scientific research; decisions based upon these data have given rise to litigation as well as public controversy. In response to these developments around the world, benzene has been regulated in the U.S., Canada, Europe, and under international standards. In particular, benzene regulations in the U.S. have been the subject of extensive litigation and research for nearly 20 years.
The case law and regulation of benzene therefore represent an important dimension of its use. Because of the power of government to implement standards and enforce the law, legal considerations ultimately affect workers' daily exposure, despite the inherent differences between law and science. Regardless of whether future developments recognize a threshold of safety for benzene use, an industrial users of benzene need to understand these laws and regulations when designing industrial hygiene programs. In addition, there remains the potential for application of these principles to other substances or environmental laws (which are beyond the scope of this article).
Drawing upon federal statutes, case law and treaties regulating benzene, this article notes the end of the era of "unbridled discretion" for agencies that regulate the use of toxic and hazardous substances, as well as an end to the threshold question, whether occupational exposure to benzene is sufficiently dangerous to require regulation. In the U.S., the desire to regulate substances has been balanced against enhanced scientific evidence and tempered by the constraints upon economic feasibility in industry. This article therefore concludes that a farreaching transnational trend exists, favoring cautious regulations that are unlikely to be overturned.
OSHA's Benzene Regulations Present Standard for Occupational
Exposure to Benzene The U.S. standard for occupational exposure to benzene (1) was adopted under the "Occupational Safety and Health Act of 1970" ("OSH Act") (2) . It authorizes the Secretary of Labor to promulgate "occupational safety and health standards" and established the Occupational Safety and Health Administration (OSHA) to perform the agency's mission. Such standards must be "reasonably necessary or appropriate to provide safe or healthful employment or places of employment", under s3(8) (3) . According to traditional U.S. administrative law (4) , agency decisions must not be "arbitrary and capricious" (5) , and must be supported by "substantial evidence" (6) justifying the agency's policies, in order to meet the test set forth in s3 (8) .
The present permissible exposure limit, (PEL) for occupational exposure to benzene is 1 ppm (7) , [ (8) . In addition, the standard requires employee notification of monitoring results; establishment and implementation of a written program to reduce employee exposure with engineering and work practice controls; respiratory protection, protective clothing, medical surveillance, recordkeeping; and regularly scheduled medical examinations (including urine sample in the event of emergency exposures).
These technical provisions are identical to the earlier final rule for benzene exposure (9) issued by OSHA in 1978, which was subjected to extensive litigation. Because of many subtle but important minor revisions, the prior final rule was about two-thirds shorter than the present rule. The original final rule had fewer exemptions; provided detailed protection against dermal and eye contact; and required quarterly measurements unless exposure was below the action level (and "at least monthly" if in excess of the PEL), new "initial monitoring" in the event of a change in the process, and swifter examination of a urine sample in the event of emergency exposure (10) .
The present standard provides workers with important job protections, such as Medical Removal Protection (MRP) based upon hematological findings outlined in paragraphs (i) (8) (i) and (ii) (11) . MRP provides workers with the right to transfer and rate retention upon recommendation by a hematologist/internist. It also requires enhanced employee education and training, consistent with the requirements of OSHA's Hazard Communication standard (12) . In addition, the present standard provides clearer definition of "representative" sample of TWA exposure; allows a longer period of time before employee notification of monitoring results; removed the requirement that notification and compliance plans be readily available to employees at the worksite; exempts from medical surveillance certain employees who face low exposures; and reduces the number of required regular medical examinations. These modifications were designed to streamline progress towards worker protection.
Regulatory History of Benzene Exposure in the U.S.
The first evidence of risk from acute or chronic effects for exposure to benzene was recognized in 1900 (13) . According to OSHA, "the benzene-leukemia link was first identified in 1897 in a report on the leukemia death of a worker occupationally exposed to benzene" (14) . Winslow recommended a 100-ppm exposure limit in 1927 (15 (18) . In 1971, OSHA adopted the voluntary industrial limit of 10 ppm, set by the American National Standards Institute (ANSI) as part of its acceptance of "national consensus standards" (19) . In that same year, the International Labor Office (ILO), a specialized agency of the United Nations, adopted ILO Convention number 136, "Convention Concerning Protection Against Hazards Arising From Benzene," which incorporated the ACGIH's standard and set an international ceiling of 25 ppm for occupational exposure.
The National Institute for Occupational Safety and Health (NIOSH) issued a criteria document concerning the possible link between leukemia and benzene in 1974 (updated in 1976) . A request for an emergency temporary standard (ETS) to regulate occupational exposure to benzene (20) was filed in 1976, followed by further information from the National Academy of Sciences (NAS), which concluded that "benzene must be considered a suspect leukemogen" (21) . These conclusions, combined with the NIOSH recommendation, prompted OSHA to issue voluntary guidelines that limited the TWA to 1 ppm in 1977 (22) . OSHA then issued an ETS (which was defeated in the courts) followed by a proposed permanent standard (23 OSHA's 1978 benzene regulation was based on the belief that there is "no safe level" for protection against a carcinogen or a suspected carcinogen. OSHA applied its overarching "Cancer Policy" (35) to justify its view that exposures must be reduced to the "lowest feasible level" (36) . That policy creates presumption under law that there is "no safe level" of exposure for cancer-causing agents. Under this construct, the agency instituted a "risk-free" workplace policy, designed to apply "technology-forcing" standards at "the frontiers of science" (37) , thereby instituting protections at the "lowest feasible level" even if they were expensive, unnecessary, or inappropriate for immediate application in the field. Thus, the justification for changes in existing benzene regulations was based upon another policy; not scientific evidence pertaining to harms derived from ex- posure to benzene at 10 ppm or less.
OSHA argued in the Supreme Court, as it did before the lower court, "that it was the agency's position that for regulatory purposes, where a safe threshold for exposure to carcinogens was not demonstrated, it would assume that none existed . . . [OSHA] cannot await scientific resolution of the issue but has a mandate to act now ... and in the absence of ... no-effect levels or safe levels to assume that none exist" (38) . OSHA set forth the view that its statutory mission required fostering "technological feasibility" over economic concerns. This approach was endorsed in the lower court by the intervenors (a concerned party that was not named in the case), that "since no safe level of exposure to benzene can be determined, the Secretary properly concluded that under OSH Act's legislative policy, the PE L should be set at the lowest feasible point" (39) based upon the agency's statutory mandate to use the "best available evidence," and the "latest available scientific data in the field," to assure "that no employee will suffer material impairment of health . .. for the period of his working life" pursuant to s. 6 (b) (5) (40).
In response to the regulatory changes, industries affected by the rule maintained that OSHA's failure to demonstrate the "appreciable benefits" of the revised consensus standard rendered such revision contrary to the precepts of U.S. administrative law. In their view, the term "feasible" wa's limited by economic constraints, in contrast to OSHA's view that "feasible" means technologically achievable. Pointing to OSH Act's statutory language in s. 6 (b) (5), industries successfully argued that OSHA standards must be "economically feasible" for the regulated industry. Furthermore, they interpreted the term "feasible" in s. 6 (b) (5) of OSH Act to included financial costs of implementing engineering controls or new forms of protection for workers, which had not been contemplated when the statute was written (41 The Court agreed with OSHA's critics, who charged that OSHA's "risk-free" approach to regulation was impractical and presented an undue burden upon employers, workers, and commerce. Bearing in mind that an agency's primary task is to create policies and make difficult decisions, the Court was prepared to "accord OSHA great leeway," and defer to its scientific expertise if OSHA's policy reasons proved, on balance, to be supported by substantial evidence. Thus, the Court reasoned, it was unnecessary to reach the issue of costbenefit analysis.
Even when considered in light of OSHA's statutory purpose and the requirement of s 6 (g) to promulgate standards "with due regard to the urgency" of the risk, however, OSHA's contention that its enabling legislation required a "risk-free workplace" could not be justified (43) because OSHA had not shown the direct, logical correlation between the information in the record and the agency's own findings. Without such evidence in the record to provide substantial evidence for the regulations' underpinnings, this fine thread of reasoning was also absent from the agency's conclusions. In the absence of a clear nexus between the evidence in the record and the conclusions in support of agency actions, the Supreme Court declared the benzene regulations invalid.
The Supreme Court agreed with the lower court's requirement that OSHA must find, "as a threshold matter that the toxic substance in question poses a significant health risk in the workplace and that a new, lower standard is therefore 'reasonably necessary and appropriate' " (44) and that "the lack of substantial evidence of discernible benefits is highlighted when one considers that OSHA is unable to point to any empirical evidence documenting leukemia risk at 10 ppm even though that has been the permissible exposure limit since 1971" (45) . It also found that the absence of sound statistical projections did not meet the test for "reasonably necessary" regulations.
Since OSHA's case was premised upon the belief that it had statutory authority to compel employers to provide a "risk-free" workplace, the Supreme Court took particular exception to the fact that "OSHA did not ask for comments as to whether or not benzene presented a significant health risk at exposures of 10 ppm or less.
Rather, it asked for comments as to whether 1 ppm was the minimum feasible exposure limit" (46) . This approach gave rise to several assumptions by OSHA regarding the absence of any safe level of exposure. In effect, the Supreme Court reasoned, "it was in fact irrelevant whether there was any evidence at all of a leukemia risk at 10 ppm" (47).
Without further guidance from OSHA, the Supreme Court was obliged to engage in "statutory construction", (a form of legal analysis) to interpret "feasible." Confronted with a situation where the Supreme Court could not rely upon administrative criteria to evaluate "science issues," it sought a middle ground by requiring a finding or "significant risk" to be determined by the agency itself. In the alternative, the Supreme Court could have declared the statute invalid (as Justice Rehnquist argued in his opinion, concurring in part and dissenting in part). Although the Supreme Court refused to construe the term "feasible" as requiring an economic cost-benefit analysis, it was compelled to forge a new standard of feasibility, based upon "significant risk" of harm (48) as measured against quantified benefits, in order to "save" the statute from "overbroad" delegation (49) , which would have rendered it unconstitutional.
The Supreme Court therefore adopted a concept of risk assessment, which is required of other regulatory agencies, such as EPA and the FDA. It is worth noting, however, the Supreme Court did not offer the specific test in an acceptable risk assessment, as lower courts had done in the past. Nor did it offer the pretense that it should provide such criteria to an agency that was charged by law with developing the expertise to create occupational health standards. Rather, it gave a general description of the two extremes that could occur: too little protection or too much protection.
The Supreme Court's many opinions in this case revolve about a single theme that unifies the questions surrounding the accuracy of the agency's scientific findings and its legal burden of proof. They reflect the Supreme Court's underlying need to substitute its own view of the inherently vague language of the OSH Act to fill the void in administrative action. "Sig-nificant risk" and the rigors of providing valid "scientific evidence" present a secondary, albeit controversial aspect of the plurality opinion. Although the need for judges to understand science has become the subject of extensive debate, the Court is comprised of lawyers, not scientists; it therefore considered inappropriate for the Court to "review" beyond the procedural aspects of the agency's scientific "fact-finding."
The Benzene Case provides a good example of the courts' quest for substantial evidence of agency decisions when no safe level of exposure is recognized. Without strong arguments specific to the facts and circumstances, supporting the promulgation of the 1 ppm benzene standard, OSHA offered only "unclear" evidence to support its actions. Failing to demonstrate the presence of a balanced policy, the agency found itself in an untenable position from the standpoint of administrative law, which resulted in the Court's vacation of the standard.
Precedents Leading to the Benzene Case
In prior cases, controversy surrounding the criteria for appropriate action by an agency did not preclude further judicial inquiry, despite the traditional "presumption" of the validity of agency conclusions. As the following discussion of case law demonstrates, several substantive and procedural safeguards must be satisfied before a court will defer to an agency's exercise of its administrative discretion. This presumption of the validity of an agency's conclusions, in the face of partisan dissatisfaction with such findings can be applied to areas of scientific uncertainty, if the agency demonstrates the fairness of its proceedings and whether the information in the record is reflected in the agency's regulatory conclusions.
In the Benzene Case, OSHA asserted that the burden of disproving the validity of a rule must be borne by the affected industries. The "Administrative Procedure Act" (APA) (50), however, requires that a proponent of a rule bears the burden of proving its necessity, unless there is specific statutory language to the contrary. In such cases, the APA requirement in s556 can only be circumvented through limited means, without undermining the statute's constitutionality. For example, there was statutory language that shifted the burden of proof to the industry in the cases of Environmental Defense Fund v. EPA (51) and Certified Color Manufacturers v. Matthews (52) . In both cases, the agency's enabling legislation clearly provided that there be a presumption that a substance was unsafe unless proven otherwise. In contrast to the OSH Act, the U.S. Congress expressly required that manufacturers of pesticides certify the safety of their products before the agency could approve their regular use. OSHA, however, does not have this statutory mandate.
The statutory authority challenged in Certified Color Manufacturers prevents the use of new food additives, unless the agency explicitly certified to the contrary after a hearing or rulemaking. In that case, the industrial representatives brought suit challenging the FDA's actions, which terminated the provisional approval of Red Number 2 (pursuant to the transitional provisions of new food additive amendments). Finding that the Secretary did not act "in excess of statutory authority," the appellate court would not substitute its own judgment for the agency's conclusions and therefore deferred to the agency's expertise.
The court's deference was contingent upon substantial evidence that FDA had in fact met its burden of reviewing and using the evidence in the record to give full and fair consideration of the points raised by the industry. In Certified Color Manufacturers, this was discerned using the FDA's statutory criteria, which providedvfor two-step decisionmaking. First, a substance was deemed unsafe until proven otherwise. Then, the substance was listed in a national registry if proven to (the Secretary's) satisfaction that it was safe, (the so-called GRAS list).
The statutory authority is distinguishable from OSHA's policy judgment that there should be a presumption of no safe level as applied to the Benzene Case. Nonetheless, the FDA model is useful because it highlights the kind of information that courts request to meet a burden of proof. FDA was guided by explicit statutory criteria that guided its decisions, which included possible harm or other relevant exposure from an additive; cumulative effect of the regulated substance; safety factors appropriate for animal experimentation data; and availability of implementation of the standard. It is worth noting that the last two components of these criteria evoke an assessment of the risks and the costs of implementation. In addition, FDA was bound by, and demonstrated compliance with, its own criteria, which provided further justification for its refusal to certify the safety of the food additives in question.
When applying these criteria in Certified Color Manufacturers, the Agency (FDA) necessarily struck the balance for weighing the potential benefits to industry (of allowing the use of questionably safe substances) against the cost to society if the substance later proved to be hazardous. Despite this concomitant reduction in unquestioned aspects of the agency's burden of proof (when compared to vague allocation of the burden of proof under OSH Act), the Court nonetheless expressed a strong concern for the quality of the Agency's scientific record. The Court deferred to FDA only after it had examined both the content imposes a health standard upon industrial establishments that is considerably more stringent than that which apparently has been found satisfactory by many states . . . (OSHA) has an obligation to produce some evidence justifying its action. (55) OSHA attempted to justify its actions in Associated Industries by asserting that the standard in question was valid, pursuant to OSHA's statutory authority, to require that workplaces be "free from recognized hazards" (56).
However, without substantial evidence relating to the need for a more stringent standard, OSHA's arguments seemed simplistic, or at best, weak enough to support virtually any discretionary action by an agency (regardless of invalidity). Finding that judicial review was "exacerbated by the absence of legitimate, nonpecuniary, articulated rationale for the standard in question," the court concluded that when OSHA sought to institute a more stringent standard, "and the proposed standard has been contested on substantial grounds, the agency has the burden of offering some explanation for adopting the Standard" (57 The Court undertook the "prodigious task" of studying the 4000 page record, which it criticized as: aggrevated duplications of testimony, irrelevant exhibits and letters, and almost illegible . . . and a general blunderbuss approach ... (60) Nonetheless, in SPI, when the court looked with "alarm" upon the "morbid" chronology of vinyl chloride exposure, unchecked by industry, even after the causal relation between occupational exposure and increased There is a major distinction in OSHA's use of the term "no safe level" in AISI compared to the Benzene Case, as the harms from coke oven emissions were an undisputed fact and there was evidence in the record that occupationally induced mortality could be improved by reducing occupational exposure to coke oven emissions. In fact, acceptance of this fact, among industries as well as regulatory authorities, served as the basic rationale for enforcing a stringent performance standard. The viability of OSHA's standard, whose efficacy was established through the use of a dose-response relationship, therefore was the sole scientific question before the court.
Thus, AISI's refusal to institute occupational health protections despite an undisputed and quantified risk of cancer was far less defensible than API's contention that costly engineering controls to meet OSHA's requirements in the face of uncertain risk would "bankrupt the industry." When viewed in light of this precedent, OSHA's arguments could not withstand strict scrutiny to prevail in the Benzene Case.
Impact of the Benzene Case Upon OSHA Case Law and New Standards
The Benzene decision had important ramifications for all subsequent OSHA standards. Despite the Court's strict scrutiny of OSHA's decisions (which called into question OSHA' statutory authority), the findings nonetheless upheld the notion that benzene is an appropriate substance for regulation and set the tone for acceptance of similar standards in the U.S. and abroad. Additionally, the decision became the touchstone for further evaluation of the role of risk assessment in lieu of costbenefit analysis within OSHA's regulatory process.
The ensuing debate regarding the importance of economic considerations (despite the prohibitions against cost-benefit analysis under OSH Act) has overshadowed the Court's rejection of this notion, because of a new, cost-containing regulatory outlook, and Executive Order, and increased oversight by OMB. The impact of the Benzene Case upon future standards promulgated by OSHA is nonetheless evident in the Agency's increased ability to demonstrate the policy rationale behind its actions.
For example, in the case of the Building Construction Trades Dept (AFL-CIO) v. Brock ("Building Trades") (67) decided in February, 1988, the Court of Appeals upheld most of OSHA's modifications to the pre-existing asbestos standard. In Building Trades, the DC Court of Appeals reviewed the modifications of OSHA's asbestos standard, which reduced the prior PEL to 0.2 and the STEL through work practice and engineering controls except for subgroups in the construction trades. OSHA's ban on the spraying of asbestos-containing products, however, was not upheld (68) .
This was the second Court of Appeals case that challenged OSHA's rulemaking for asbestos; the first round of litigation began with OSHA's initial asbestos standard in 1974 (69). In IUD v. Hodgson (70), the court examined whether OSHA had authority to institute controls for occupational exposure to asbestos that were mandated by statute, (i.e., recordkeeping and medical examinations) (71) . The court reluctantly upheld OSHA's exercise of authority to establish such controls and to set the time frame for their implementation, stating, "the record, examined closely in relation to the relevant concerns of the Act leaves nagging questions-even for the inexpert observer-as to the reasons and rationale for the Secretary's particular choices" (72) .
In Building Trades, the same court reviewed the same agency's actions regarding the same substance, 15 years later. The opinion in Building Trades is therefore striking in its complexity and its sophisticated evaluation of scientific data (73) . By contrast to Hodgson's simplistic view that "technological progress in industry appears not to have been accompanied uniformly by corresponding reductions in the health hazards" (74) , the court in Building Trades made frequent references to epidemiology and discussed throughout its opinion such nonlegal concepts as odds ratios, standard mortality, and proportionate mortality (75) . It also included in the body of its opinion a chart that shows the relative risk for smokers versus nonsmokers who are occupationally exposed to asbestos over a working lifetime. The court further stated "Even under the assumption of a 20 year working life, [OSHA] found the risk at the existing PEL to be 44 extra cancer deaths per 1000" (76). It therefore accepted OSHA's threshold determination that even at reduced levels there exists a significant risk, which would be measurably reduced by implementation of the modified standard.
OSHA's position regarding its threshold findings ofrisk due to occupational exposure to asbestos were based upon its interpretation of the Benzene Case. Although the agency chose to apply a very narrow interpretation of the "significant risk" doctrine, the court was satisfied by this approach. It deferred, in large part, to the agency's findings except when the terminology used by the agency was unduly vague (7? ). The court's refusal to accept a ban on the spraying of products that contain asbestos and its desire for a clearer definition of the phrase "any kind of construction work" (77) when determining the scope of exemptions from the standard represent two instances where the absence of evidence in the record compelled the court to reject OSHA's policy.
The court agreed with OSHA, however, that despite the synergistic relationship between asbestos and smoking which increased the workers risk, there was no justification to require that employers institute an outright ban on smoking by all persons who face occupational exposure to asbestos (78) .
The language used by the court throughout the Building Trade opinion (which concerns modified asbestos regulations) closely resembles the preamble to the present (second) final benzene regulation, issued only a few months before the Building Trades decision (79). The benzene regulations' preamble reflects a heightened awareness of technical matters to support QSHA's "determination by the Assistant Secretary that employees exposed to benzene face a significant heightened risk and that this standard will substantially reduce that risk" (80) . The agency's use of technical language and its long discussion of whether benzene is an initiator or a promoter (81) is clearly derived from the Benzene Case, which was cited in the preamble (82) . For example, OSHA described the "extended and upgraded" work in studies by Infante and Rinsky (case control and retrospective studies of refinery workers) and by Aksoy (leukemia and pancytopenia among shoe workers in Istanbul (83), as well as major developments in new studies (84) . These and other studies were assessed by an outside consultant for OSHA. In addition, the lengthy preamble discussed standard mortality ratios and the findings of studies on rats and mice and concluded, "the new standard creates a minimum reduction in excess risk of 90%o [which will] prevent a minimum of 326 deaths from leukemia over 45 years" (85) . This new approach indicates a concern for the evidentiary underpinnings at the heart of the Benzene Case. Although there are no cases at the present time that pertain specifically to the benzene convention, the ILO also provides for an elaborate oversight mechanism and grievance procedure in the event of violation of a standard after it has been ratified by a nation. And, in rare cases of egregious behavior, a nation's compliance with international standards may be called into question at the annual International Labor Conference (ILC), even if the offending nation has not ratified the convention. This concept of "entry into force" is an important and highly controversial aspect of international law. For the purposes of benzene regulation, however, this concept holds greater implications for nations who have not created standards of their own, rather than to nations who have exercised their power in favor of regulation. Employers who seek to protect their employees in nations where no standards presently exist also are affected by the international benzene standard.
The European Economic Community (EEC) instituted community-wide standards for the transport and handling of toxic substances that became effective in the early 1980s. Like most EEC agreements, the standards function as a treaty but also espouse principles that many ripen into customary international law. While the transport agreement does not specify exposure limits to toxic substances, it does set forth required procedures for the safe handling and use of covered substances in a manner that closely resembles the subsequent labeling requirements under U.S. laws. By contrast, the WHO has published Air Quality Guidelines, which state, "No safe level for airborne benzene can be recommended, as ... there is no known safe carcinogenic level" (90) . Unlike standards, however, these guidelines are not designed to be a part of international law. Rather, they reflect the scientific consensus regarding specific substances, including benzene, following WHO's constitutional mandate to protect and promote health around the world (91) .
Last, Canada's province of Ontario provides an example of regional benzene regulations that reflect state-ofthe-art science and involvement by government, employers, and workers, consistent with the ILO's model. The pattern of consultation between these parties resembles the structure contemplated in the ILO Convention and its constitution. In addition, these benzene regulations, passed in 1984, require respirators whenever engineering controls are not available "to the lowest practible level" (92) .
These examples highlight the growing international consensus that occupational exposure to toxic or hazardous substances is a proper subject for national, transnational, and even international regulation.
Conclusions
Benzene has become as ubiquitous in law as it is in industry due to protracted litigation and pervasive regulation. Although regulatory agencies have limited power, it is unrealistic to expect that interest in regulation will soon diminish or that the plethora of existing regulations will be reduced in their scope or rigor. Indeed, the regulatory trend is toward more stringent regulation through the adoption of more conservative, scientifically based preventative measures. Such regulations are more likely to withstand judicial scrutiny and remain enforceable as widely accepted norms before national fora and under international law.
